当前位置: 首页 SCI 期刊 Kidney360(非官网)
Kidney360

Kidney360SCIE

国际简称:KIDNEY360  参考译名:肾脏360

  • CiteScore分区

    Q2

  • JCR分区

    Q1

基本信息:
ISSN:2641-7650
是否OA:未开放
是否预警:否
出版信息:
出版商:Wolters Kluwer Health
出版语言:English
研究方向:UROLOGY & NEPHROLOGY
评价信息:
影响因子:3.2
CiteScore指数:3.9
SJR指数:0.83
SNIP指数:0.75
发文数据:
Gold OA文章占比:99.84%
研究类文章占比:87.25%
年发文量:204
英文简介 期刊介绍 CiteScore数据 JCR分区 常见问题

英文简介Kidney360期刊介绍

Kidney360 strives to be the top academic platform in the field of nephrology worldwide, with the goal of providing a wide range of knowledge resources and cutting-edge research results for nephrologists, kidney pathologists, and scientists and medical professionals interested in kidney disease. The platform covers the latest kidney disease research, diagnostic technologies and treatments, and is committed to promoting academic exchange and collaboration. By publishing high-quality research papers, review articles and clinical guidelines, we hope to provide important reference materials and data support for the global academic community and clinical practice. In addition, the platform will provide webinars, lectures and training courses to help professionals constantly update their knowledge and improve their skills to better address the challenges of kidney disease. In summary, the aim is to promote knowledge sharing and innovation in the field of nephrology by integrating the world's leading scientific research results and clinical experience, ultimately leading to more effective disease management and patient care.

期刊简介Kidney360期刊介绍

《Kidney360》该刊近一年未被列入预警期刊名单,目前已被权威数据库SCIE收录,得到了广泛的认可。

该期刊投稿重要关注点:

  • 预计审稿时间:
  • SCIE
  • 非预警

Cite Score数据(2024年最新版)Kidney360 Cite Score数据

  • CiteScore:3.9
  • SJR:0.835
  • SNIP:0.748
学科类别 分区 排名 百分位
大类:Medicine 小类:Medicine (miscellaneous) Q2 143 / 398

64%

大类:Medicine 小类:Nephrology Q2 31 / 81

62%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础,针对的是前四年发表的论文的引文。CiteScore的意义在于,它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法,而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

JCR分区Kidney360 JCR分区

2023-2024 年最新版
按JIF指标学科分区 收录子集 分区 排名 百分位
学科:UROLOGY & NEPHROLOGY ESCI Q1 24 / 126

81.3%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:UROLOGY & NEPHROLOGY ESCI Q1 31 / 126

75.79%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异,此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此,JCR将期刊按照学科门类和影响因子分为不同的分区,这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

投稿常见问题